Search Results 61 – 80 of 229
Date:
Source: Meeting the Challenge of Engaging Men in HIV Prevention and Treatment
Date:
Source: Cost Data for Symtuza Added to Table 17 of Adult and Adolescent ARV Guidelines
Date:
Source: Combination HIV Antibody Infusions Safely Maintain Viral Suppression in Select Individuals
Date:
Source: NIH Launches Study to Test Combination Antibody Treatment for HIV Infection
Date:
Source: NIH Funds Study to Prevent, Treat HIV Among Adolescents in Poor Countries
Date:
Source: Novel Intervention Halves Rate of Death Among People Living with HIV Who Inject Drugs
Date:
Source: HIV/AIDS Research Yields Dividends Across Medical Fields
Date:
Source: NIH Officials: Closing Treatment Gaps Critical to Ending the U.S. HIV Epidemic
Date:
Source: During HIV Infection, Antibody Can Block B Cells From Fighting Pathogens
Date:
Source: Multi-Disease Health Fairs, Universal "Test and Treat" Help East African Communities Achieve HIV Benchmarks
Date:
Source: Fauci: HIV Remission Free of Antiretroviral Therapy Is a Feasible Goal
Date:
Source: Imaging Technique Illuminates Immune Status of Monkeys with HIV-Like Virus
Date:
Source: HIV Vaccine Elicits Antibodies in Animals that Neutralize Dozens of HIV Strains
Date:
Source: Recommendations Regarding the Use of Dolutegravir in Adults and Adolescents with HIV who are Pregnant or of Child-Bearing Potential
Date:
Source: Statement on Potential Safety Signal in Infants Born to Women Taking Dolutegravir
Date:
Source: FDA Drug Safety Communication: FDA to Evaluate Potential Risk of Neural Tube Birth Defects with HIV Medicine Dolutegravir
Date:
Source: Clinical Trial to Track Outcomes of Kidney Transplantation from HIV+ Donors to HIV+ Recipients
Date:
Source: Anti-HIV Drug Combination Does Not Increase Preterm Birth Risk
Date:
Source: Genetically Altered Broadly Neutralizing Antibodies Protect Monkeys From HIV-Like Virus
Date:
Source: Adult ARV Panel Classifies BIC/TAF/FTC as Recommended Initial Regimen for HIV